(Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 289.21%12.29B | -46.22%3.44B | -2,795.74%-3.8B | -46.49%12.15B | 36.56%12.11B | -181.72%-6.5B | -6.88%6.4B | 114.49%141M | 781.72%22.72B | 6.76%8.87B |
Net income from continuing operations | 25.35%1.8B | 3.55%1.75B | 299.08%1.73B | -19.38%5.03B | 24.81%1.48B | -14.05%1.43B | 10.90%1.69B | -76.83%433M | -3.15%6.24B | -17.71%1.19B |
Operating gains losses | 88.89%-3M | 8.82%-31M | -50.00%-15M | -109.76%-86M | -266.67%-15M | -80.00%-27M | -100.00%-34M | 44.44%-10M | 54.44%-41M | 140.91%9M |
Depreciation and amortization | 15.69%317M | 2.13%288M | -0.36%276M | 9.17%1.14B | 11.51%310M | 5.38%274M | 10.16%282M | 9.49%277M | 2.95%1.05B | -3.14%278M |
Provision for loans, leases and other losses | -34.38%483M | 17.35%514M | 98.31%585M | 90.16%2.01B | 24.08%541M | 202.88%736M | 44.55%438M | 293.33%295M | 568.99%1.06B | 458.97%436M |
Remuneration paid in stock | 0.00%3M | 33.33%4M | 0.00%2M | -45.83%13M | -44.44%5M | 0.00%3M | 0.00%3M | -77.78%2M | 26.32%24M | 350.00%9M |
Deferred tax | 64.52%-22M | -128.16%-58M | 114.44%39M | -89.13%-87M | 133.05%39M | -100.00%-62M | 2,188.89%206M | -387.23%-270M | -12.20%-46M | -972.73%-118M |
Other non cashItems | -167.95%-1.08B | 20,000.00%201M | -1,250.00%-690M | 261.81%1.82B | 122.77%179M | 669.06%1.58B | -97.78%1M | 156.07%60M | -221.47%-1.13B | -267.23%-786M |
Change in working capital | 203.43%10.79B | -79.67%776M | -786.38%-5.73B | -85.18%2.31B | 21.85%9.57B | -271.03%-10.43B | -19.69%3.82B | 79.48%-646M | 232.20%15.56B | 29.57%7.85B |
-Change in receivables | -50.93%53M | 15.78%-475M | 78.13%-63M | -32.64%-1.27B | 0.75%-528M | 157.45%108M | -48.42%-564M | -304.26%-288M | -2,184.78%-959M | -212.94%-532M |
-Change in payables and accrued expense | -132.02%-130M | -37.57%565M | -73.23%197M | 105.29%2.52B | -43.50%474M | 82.88%406M | 330.95%905M | 1,811.63%736M | 393.08%1.23B | 635.96%839M |
-Change in loans | 1,050.99%9.28B | -46.12%-10.86B | 344.89%10.02B | 74.66%-15.95B | 41.99%-5.24B | 106.06%806M | 55.56%-7.43B | 82.90%-4.09B | -23.19%-62.96B | 48.65%-9.03B |
-Change in other working capital | 113.54%1.59B | 5.83%11.54B | -629.91%-15.88B | -78.26%17.01B | -10.35%14.86B | -160.70%-11.75B | -49.61%10.91B | -85.50%3B | 97.04%78.25B | -30.07%16.58B |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 289.21%12.29B | -46.22%3.44B | -2,795.74%-3.8B | -46.49%12.15B | 36.56%12.11B | -181.72%-6.5B | -6.88%6.4B | 114.49%141M | 781.72%22.72B | 6.76%8.87B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -676.00%-9.34B | 72.51%-1.66B | 5.18%-8.68B | 14.87%-20.76B | -34.50%-4.35B | 38.73%-1.2B | 37.12%-6.05B | 4.29%-9.16B | -595.69%-24.39B | 18.94%-3.24B |
Net PPE purchase and sale | -15.55%-275M | 11.67%-212M | 15.04%-209M | 8.57%-1.01B | 26.02%-290M | 12.50%-238M | 1.64%-240M | -22.39%-246M | -32.18%-1.11B | -45.19%-392M |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---3.09B | ---7M |
Net investment purchase and sale | -838.72%-9.07B | 75.02%-1.45B | 4.91%-8.47B | 2.22%-19.75B | -43.19%-4.06B | 42.94%-966M | 7.79%-5.81B | 4.86%-8.91B | -657.29%-20.2B | 23.78%-2.84B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -676.00%-9.34B | 72.51%-1.66B | 5.18%-8.68B | 14.87%-20.76B | -34.50%-4.35B | 38.73%-1.2B | 37.12%-6.05B | 4.29%-9.16B | -595.69%-24.39B | 18.94%-3.24B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -156.61%-1.57B | 66.47%-447M | 66.33%657M | -34.10%-2.16B | -202.49%-608M | 22.50%-613M | -679.57%-1.33B | 146.58%395M | 17.22%-1.61B | -527.66%-201M |
Net issuance payments of debt | -632.14%-615M | 90.64%-78M | 30.72%1.2B | -112.05%-81M | 6.82%-82M | -3.70%-84M | -190.84%-833M | 1,307.89%918M | 314.70%672M | -7.32%-88M |
Net commonstock issuance | 45.24%61M | 39.13%64M | 14.58%55M | 92.63%183M | 17.50%47M | -10.64%42M | -6.12%46M | 217.07%48M | -64.68%95M | -21.57%40M |
Net preferred stock issuance | ---152M | --173M | ---- | --0 | --0 | --0 | --0 | ---- | -20.45%595M | -20.19%597M |
Cash dividends paid | -51.84%-867M | -10.99%-606M | -4.73%-598M | 23.92%-2.26B | 23.60%-573M | 24.37%-571M | 25.82%-546M | 21.89%-571M | -12.19%-2.97B | -11.94%-750M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -156.61%-1.57B | 66.47%-447M | 66.33%657M | -34.10%-2.16B | -202.49%-608M | 22.50%-613M | -679.57%-1.33B | 146.58%395M | 17.22%-1.61B | -527.66%-201M |
Net cash flow | ||||||||||
Beginning cash position | -53.06%10.3B | -61.05%8.91B | -33.99%20.82B | -8.79%31.54B | -47.80%13.55B | 5.65%21.94B | -1.65%22.88B | -8.79%31.54B | -20.58%34.57B | -14.17%25.95B |
Current changes in cash | 116.52%1.37B | 235.37%1.33B | -37.20%-11.83B | -227.69%-10.77B | 31.64%7.15B | -260.09%-8.31B | 60.97%-984M | 24.30%-8.62B | 62.59%-3.29B | 24.52%5.43B |
Effect of exchange rate changes | 114.29%12M | 16.33%57M | -102.50%-81M | -80.24%49M | -20.51%124M | -740.00%-84M | 63.33%49M | -155.56%-40M | 241.71%248M | 842.86%156M |
End cash position | -13.74%11.68B | -53.06%10.3B | -61.05%8.91B | -33.99%20.82B | -33.99%20.82B | -47.80%13.55B | 5.65%21.94B | -1.65%22.88B | -8.79%31.54B | -8.79%31.54B |
Free cash from | 278.43%12.01B | -47.57%3.23B | -3,719.05%-4.01B | -48.44%11.14B | 39.45%11.82B | -187.71%-6.73B | -7.07%6.16B | 91.06%-105M | 618.01%21.61B | 5.46%8.47B |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data